US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers: market research reports

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers can be valuable tools in clinical diagnostics as well as in therapeutic discovery and development.
They can be used to predict response to therapy or risk of side effects for personalized medicine applications. Additional types include predisposition, screening, diagnostic, prognostic, toxicity, pharmacodynamic, and other biomarkers.

The existence of living organisms or biological processes, a particular disease state, or a fragment of DNA sequence can indicate biomarkers. Locations of a particular molecule (cellular or subcellular, tissue or organ locations) can also be a biomarker.

Biomarkers ideal for diagnosis should have great sensitivity, specificity, and accuracy in reflecting total disease burden. A tumor marker should also be prognostic of outcome and predictive of tumor recurrence and effectiveness of anti-cancer treatments.

Biomarkers for screening purposes must be highly specific, minimizing false positive and negative results. The biomarker must be able to clearly reflect the early stage of disease and it must be easily detected without complicated medical procedures. The disease markers released to serum and urine are good targets for application of early screening. The method for screening should be cost effective. Biomarkers are commonly detected through blood, urine, other body fluids, and tissue samples.

Biomarkers play a major role in medicinal biology. Biomarkers bring the future things in our hand by helping in early diagnosis, disease prevention, drug target identification, drug response etc. Several disease-based biomarkers had been identified for many diseases such as serum LDL for cholesterol, blood pressure, P53 gene and MMPs for cancer. Gene based biomarkers are found to be effective and acceptable markers in the present scientific world.

RSS Feeds

Biomarkers market research reports and industry analysis

< prev 1    3  4  5  6  
Companion Diagnostics Market
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs.  It also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
Biomarkers in Alzheimer's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the ...  |  read more...
USD 699
Biomarker Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Biomarkers in Parkinson's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Neurodegenerative Disorders, this report focuses on the Parkinson’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing ...  |  read more...
USD 699
Biomarkers in Amyotrophic Lateral Sclerosis
8/1/2014 | published by: CHI Insight Pharma Reports
... a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With ...  |  read more...
USD 699
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
7/1/2014 | published by: CHI Insight Pharma Reports
... development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders. Although there are many techniques used to track neurodegenerative disease progression, this report will ...  |  read more...
USD 2,495
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024
6/25/2014 | published by: Visiongain
... medicines? Now get the latest analysis for that industry. There you explore developments (R&D), results, opportunities, trends and revenue forecasts. Visiongain’s updated report shows you what’s possible for those drugs, diagnostic tests and related technology. ...  |  read more...
USD 3,004
Tumor Markers: Unlocking the Mistery of the Genetic Basis of Cancer - Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
6/26/2014 | published by: Venture Planning Group
... markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market segment - Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for ...  |  read more...
USD 24,500
Immunodiagnostics: Spot Fast-Growing Market Segments - Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
6/26/2014 | published by: Venture Planning Group
... and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report ...  |  read more...
USD 24,500
Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Glo
6/26/2014 | published by: MarketsandMarkets
... report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), ...  |  read more...
USD 4,650
Analysis of the Western European Biomarkers Market in Drug Discovery and Development
6/13/2014 | published by: Frost & Sullivan
... were conducted with leading tier 1 and tier 2 companies and industry stakeholders, such as key clinicians, the research and development (R&D) community, heads of business development, laboratory personnel and key opinion leaders. Secondary data ...  |  read more...
USD 7,500
MicroRNAs in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... with minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us ...  |  read more...
USD 6,746
Mass Spectrometry in Clinical Applications
4/29/2014 | published by: Kalorama Information
... and End User Survey , looks at the growth of Mass Spec systems being used in diagnostics and other clinical applications this year.  A Detailed Examination of the Market Opportunity for MS in Clinical Applications ...  |  read more...
USD 4,400
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Blood Markers, Endocrine Markers, Infectious Disease and Neurological Disease Markers)
10/16/2013 | published by: Kalorama Information
... medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease.  With them, diseases are detected earlier, more effective treatments can ...  |  read more...
USD 3,995
Biomarkers: Technologies and Global Markets
4/1/2014 | published by: BCC Research
... An overview of the global market for biomarkers. Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018. Assessments of companies poised to introduce ...  |  read more...
USD 6,650
Biomarkers
6/1/2014 | published by: RI Technologies
... Deficiencies, Hepatic, Renal, and Bone related Diseases. The market is further divided by various therapeutic areas such as - Prostate Cancer, Ovarian Cancer, Breast Cancer, Lung Cancer and Other for Oncology segment; Coronary Heart Diseases, ...  |  read more...
USD 4,680
MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview
4/1/2014 | published by: CHI Insight Pharma Reports
... it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding nature and ability to affect ...  |  read more...
USD 2,495
Conference Documentation: Oncology imaging for drug development
3/12/2014 | published by: SMI Publishing, Ltd
... consider the current landscape of personalised imaging within the field of oncology. SMi's 10th annual event on oncology imaging will provide delegates with a comprehensive insight into current and future legislation and its impact on ...  |  read more...
USD 788.78
Biomarker Partnering Terms and Agreements
4/1/2014 | published by: Current Partnering
... in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to ...  |  read more...
USD 2,995
JAK and PI3K Signaling Pathway Markets
4/1/2014 | published by: BCC Research
... billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018. This report provides: An overview of the global market for signal transduction therapies and inhibitors ...  |  read more...
USD 6,650
Biotechnology: Circulating Tumor Cells (CTC) Technologies
4/1/2014 | published by: RI Technologies
... Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC industry, covering more than 150 companies that are engaged in CTC studies/screening, products and services. ...  |  read more...
USD 5,400
Biomarker Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends and Forecasts (2013 – 2
9/25/2013 | published by: MarketsandMarkets
... and measurable characteristic, which identifies the severity and/or occurrence of a specific disease. It has major applications in the discovery and development of novel therapeutic drugs. The global biomarkers market shows a high growth potential ...  |  read more...
USD 4,650
World Tumor Markers Testing Market 2014: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
1/22/2014 | published by: Venture Planning Group
... years - Examines trends in the U.S., Europe and Japan - Reviews current and emerging tumor markers - Analyzes applications of emerging diagnostic technologies - Forecasts sales of major tumor markers by country and market ...  |  read more...
USD 32,500
Global Imaging Biomarkers Market 2014-2018
11/22/2013 | published by: TechNavio - Infiniti Research Ltd.
... cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market. TechNavio's report, the ...  |  read more...
USD 2,000
< prev 1    3  4  5  6